Results 121 to 130 of about 2,190,849 (297)
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Micro-RNAs in breast cancer progression and metastasis: A chromatin and metabolic perspective
Breast cancer is a highly complex disease with multiple subtypes. While many of the breast cancer cases are sporadic some can be familial or hereditary.
Sweta Sikder +4 more
doaj +1 more source
Comprehensive analysis of NAC transcription factors uncovers their roles during fiber development and stress response in cotton [PDF]
Heng Sun +7 more
openalex +1 more source
Unraveling the role of MADS transcription factor complexes in apple tree dormancy [PDF]
Vítor da Silveira Falavigna +10 more
openalex +1 more source
Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson +2 more
wiley +1 more source
HAND2 Targets Define a Network of Transcriptional Regulators that Compartmentalize the Early Limb Bud Mesenchyme [PDF]
Marco Osterwalder +12 more
openalex +1 more source
Functional Hierarchy and Cooperation of EMT Master Transcription Factors in Breast Cancer Metastasis [PDF]
Joseph Addison +12 more
openalex +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source

